Other
1st Quarter 2017
Sales in Other rose considerably year-on-year, mainly as a result of increased prices in raw materials trading. Income from operations before special items fell considerably. This was predominantly a consequence of valuation effects for our long-term incentive program.
|
|
1st Quarter |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
|
|
2017 |
2016 |
Change % |
||||||
|
||||||||||
Sales |
|
610 |
477 |
28 |
||||||
Income from operations before depreciation and amortization (EBITDA) |
|
(216) |
(211) |
(2) |
||||||
Amortization and depreciation1 |
|
27 |
34 |
(21) |
||||||
Income from operations (EBIT) |
|
(243) |
(245) |
1 |
||||||
Special items |
|
7 |
(26) |
. |
||||||
EBIT before special items |
|
(250) |
(219) |
(14) |
||||||
Thereof Costs for cross-divisional corporate research |
|
(81) |
(99) |
18 |
||||||
Costs of corporate headquarters |
|
(52) |
(55) |
5 |
||||||
Other businesses |
|
5 |
18 |
(72) |
||||||
Foreign currency results, hedging and other measurement effects |
|
(31) |
68 |
. |
||||||
Miscellaneous income and expenses |
|
(91) |
(151) |
40 |
||||||
Assets (March 31)2 |
|
9,793 |
12,096 |
(19) |
||||||
Investments including acquisitions3 |
|
31 |
16 |
94 |
||||||
Research and development expenses |
|
85 |
100 |
(15) |